• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YKL-40和透明质酸(HA)作为丙型肝炎病毒慢性感染的肾移植患者肝纤维化的非侵入性标志物。

YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection.

作者信息

Schiavon Leonardo L, Carvalho-Filho Roberto J, Narciso-Schiavon Janaína L, Medina-Pestana José O, Lanzoni Valéria P, Ferraz Maria Lucia G, Silva Antonio Eduardo B

机构信息

Division of Gastroenterology, Federal University of Sao Paulo, Sao Paulo, Brazil.

出版信息

Scand J Gastroenterol. 2010 May;45(5):615-22. doi: 10.3109/00365521003637203.

DOI:10.3109/00365521003637203
PMID:20163287
Abstract

OBJECTIVE

Hepatitis C is highly prevalent among kidney transplant (KT) recipients. In this population, the natural history of hepatitis C virus (HCV) infection and its proper management remains controversial. The invasiveness of the procedure and the interpretation variability of liver biopsy limit its use in these patients. We sought to evaluate the performance of YKL-40 and HA as markers of liver fibrosis in KT patients with HCV infection.

MATERIAL AND METHODS

This cross-sectional study included HCV infected KT individuals. Univariate analysis was used to identify variables associated with significant fibrosis (METAVIR >or= F2). The diagnostic values of the YKL-40 and HA were compared using receiver operating characteristic (ROC) curves.

RESULTS

Eighty-five patients were included (60% males, mean age 44.9 +/- 9.4 years). Significant fibrosis was observed in 14 patients (17%). When compared to F0/F1 individuals, patients with significant fibrosis were older, showed a higher time since transplantation, and higher prevalence of diabetes. No difference was observed in YKL-40 levels between the groups. Significantly higher levels of HA were noted in METAVIR >or= F2 subjects (108 vs. 37 ng/ml, p = 0.002). The AUROCs of YKL-40 and HA for predicting significant fibrosis were 0.615 and 0.765, respectively (p = 0.144). Levels of YKL-40 <or= 105 ng/ml and of HA <or= 27 ng/ml showed a NPV of 36% and 96%, respectively. YKL-40 >or= 418 ng/ml and HA >or= 120 ng/ml exhibited a PPV of 31% and 39%, respectively.

CONCLUSIONS

Increased serum levels of HA but not of YKL-40 were associated with more advanced stages of liver fibrosis in KT HCV-infected patients.

摘要

目的

丙型肝炎在肾移植(KT)受者中高度流行。在这一人群中,丙型肝炎病毒(HCV)感染的自然史及其恰当管理仍存在争议。该检查的侵入性以及肝活检结果解读的变异性限制了其在这些患者中的应用。我们试图评估YKL-40和透明质酸(HA)作为HCV感染的KT患者肝纤维化标志物的性能。

材料与方法

这项横断面研究纳入了HCV感染的KT个体。采用单因素分析来确定与显著纤维化(METAVIR≥F2)相关的变量。使用受试者工作特征(ROC)曲线比较YKL-40和HA的诊断价值。

结果

纳入85例患者(60%为男性,平均年龄44.9±9.4岁)。14例患者(17%)观察到显著纤维化。与F0/F1个体相比,有显著纤维化的患者年龄更大,移植后时间更长,糖尿病患病率更高。两组间YKL-40水平无差异。METAVIR≥F2的受试者中HA水平显著更高(108 vs. 37 ng/ml,p = 0.002)。YKL-40和HA预测显著纤维化的曲线下面积(AUROC)分别为0.6

相似文献

1
YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection.YKL-40和透明质酸(HA)作为丙型肝炎病毒慢性感染的肾移植患者肝纤维化的非侵入性标志物。
Scand J Gastroenterol. 2010 May;45(5):615-22. doi: 10.3109/00365521003637203.
2
Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.血清YKL-40和透明质酸水平作为慢性丙型肝炎病毒感染血液透析患者肝纤维化的非侵入性标志物。
J Viral Hepat. 2008 Sep;15(9):666-74. doi: 10.1111/j.1365-2893.2008.00992.x. Epub 2008 May 14.
3
Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C.血清透明质酸、FIBROSpect II和YKL-40在鉴别慢性丙型肝炎纤维化分期中的诊断准确性
Am J Gastroenterol. 2008 Apr;103(4):928-36. doi: 10.1111/j.1572-0241.2007.01761.x. Epub 2008 Mar 25.
4
Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience.血清生物标志物和瞬时弹性成像在美国队列中预测晚期肝纤维化的价值:波士顿儿童医院的经验。
J Pediatr. 2013 Oct;163(4):1058-64.e2. doi: 10.1016/j.jpeds.2013.04.044. Epub 2013 Jun 5.
5
Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease.通过血清纤维化生成标志物YKL-40对丙型肝炎病毒相关性肝病患者的肝纤维化及干扰素治疗反应进行无创评估。
World J Gastroenterol. 2005 Jan 28;11(4):476-81. doi: 10.3748/wjg.v11.i4.476.
6
Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.埃及慢性丙型肝炎患者纤维化和损伤血清生物标志物的评估
J Hepatol. 2007 Apr;46(4):620-7. doi: 10.1016/j.jhep.2006.12.010. Epub 2007 Jan 24.
7
YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis.YKL-40与瞬时弹性成像技术:评估肝纤维化的有力组合。
Scand J Gastroenterol. 2011 Nov;46(11):1369-80. doi: 10.3109/00365521.2011.613949. Epub 2011 Sep 12.
8
Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C.血清纤维化标志物可预测丙型肝炎肝移植后纤维化的快速进展。
Liver Transpl. 2008 Sep;14(9):1294-302. doi: 10.1002/lt.21508.
9
Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.慢性丙型肝炎病毒与人类免疫缺陷病毒合并感染患者的透明质酸、转化生长因子-β1与肝纤维化
J Viral Hepat. 2009 Jul;16(7):513-8. doi: 10.1111/j.1365-2893.2009.01103.x. Epub 2009 Feb 5.
10
Prediction of significant liver fibrosis in kidney transplant patients with chronic hepatitis C virus infection: the TX-3 index.预测慢性丙型肝炎病毒感染肾移植患者的显著肝纤维化:TX-3 指数。
J Viral Hepat. 2010 Jun;17(6):391-9. doi: 10.1111/j.1365-2893.2009.01190.x. Epub 2009 Sep 15.

引用本文的文献

1
Role of chitinase-3-like protein 1 in liver diseases: A comprehensive review.几丁质酶-3样蛋白1在肝脏疾病中的作用:综述
Genes Dis. 2025 Apr 24;12(6):101653. doi: 10.1016/j.gendis.2025.101653. eCollection 2025 Nov.
2
Diagnostic Value of Serum Chitinase-3-Like Protein 1 for Liver Fibrosis: A Meta-analysis.血清几丁质酶-3-样蛋白1对肝纤维化的诊断价值:一项Meta分析
Biomed Res Int. 2022 Mar 20;2022:3227957. doi: 10.1155/2022/3227957. eCollection 2022.
3
Reciprocal induction of hepatitis C virus replication and stimulation of hepatic profibrogenic cytokine release and cellular viability by YKL-40.
YKL-40对丙型肝炎病毒复制的相互诱导作用以及对肝脏促纤维化细胞因子释放和细胞活力的刺激作用。
Ann Transl Med. 2021 Nov;9(22):1649. doi: 10.21037/atm-21-4537.
4
Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.几丁质酶 3 样蛋白 1-CD44 相互作用通过 β-连环蛋白/Erk/Akt 信号通路促进胃癌转移和上皮间质转化。
J Exp Clin Cancer Res. 2018 Aug 30;37(1):208. doi: 10.1186/s13046-018-0876-2.
5
Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.与继续使用基于 PI/NNRTI 的抗逆转录病毒治疗相比,改用拉替拉韦后,脂联素和脂肪变性标志物 Chi3L1 下降。
PLoS One. 2018 May 10;13(5):e0196395. doi: 10.1371/journal.pone.0196395. eCollection 2018.
6
Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis.几丁质酶3样蛋白1表达增加是非小细胞肺癌的预后标志物,与肿瘤血管生成相关。
Tumour Biol. 2015 Feb;36(2):901-7. doi: 10.1007/s13277-014-2690-6. Epub 2014 Oct 12.
7
Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma.几丁质酶3样蛋白1表达增加和微血管密度可预测透明细胞肾细胞癌的转移及不良预后。
Tumour Biol. 2014 Dec;35(12):12131-7. doi: 10.1007/s13277-014-2518-4. Epub 2014 Aug 21.
8
The significance of YKL-40 protein in liver fibrosis.YKL-40 蛋白在肝纤维化中的意义。
Inflamm Res. 2014 Apr;63(4):249-54. doi: 10.1007/s00011-013-0698-9. Epub 2014 Jan 19.
9
YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?YKL-40-A 蛋白在转化医学领域:作为癌症患者的生物标志物的作用?
Cancers (Basel). 2010 Jul 12;2(3):1453-91. doi: 10.3390/cancers2031453.
10
A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.丙型肝炎纤维化评估的分子、遗传和成像技术简述。
Virol J. 2011 Feb 8;8:53. doi: 10.1186/1743-422X-8-53.